Atosiban (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Atosiban" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

13doi.org

2^nd place

6semanticscholar.org

11^th place

8^th place

2medicines.org.uk

3,823^rd place

2,387^th place

1web.archive.org

1^st place

1drugs.com

399^th place

333^rd place

1europa.eu

68^th place

117^th place

1worldcat.org

5^th place

doi.org

Akerlund M, Carlsson AM, Melin P, Trojnar J (1985). "The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin". Acta Obstetricia et Gynecologica Scandinavica. 64 (6): 499–504. doi:10.3109/00016348509156728. PMID 4061066. S2CID 25799128.
Sanu O, Lamont RF (April 2010). "Critical appraisal and clinical utility of atosiban in the management of preterm labor". Therapeutics and Clinical Risk Management. 6: 191–199. doi:10.2147/tcrm.s9378. PMC 2861440. PMID 20463780.
Chou PY, Wu MH, Pan HA, Hung KH, Chang FM (June 2011). "Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study". Taiwanese Journal of Obstetrics & Gynecology. 50 (2): 136–140. doi:10.1016/j.tjog.2011.04.003. PMID 21791296.
Lan VT, Khang VN, Nhu GH, Tuong HM (September 2012). "Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure". Reproductive Biomedicine Online. 25 (3): 254–260. doi:10.1016/j.rbmo.2012.05.014. PMID 22818095.
Wu MY, Chen SU, Yang YS (December 2011). "Using atosiban in uterine contractions of early pregnancies after assisted reproduction". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 110 (12): 800. doi:10.1016/j.jfma.2011.11.016. PMID 22248840.
Conde-Agudelo A, Romero R, Kusanovic JP (February 2011). "Nifedipine in the management of preterm labor: a systematic review and metaanalysis". American Journal of Obstetrics and Gynecology. 204 (2): 134.e1–134.20. doi:10.1016/j.ajog.2010.11.038. PMC 3437772. PMID 21284967.
Lamont RF, Kam KY (March 2008). "Atosiban as a tocolytic for the treatment of spontaneous preterm labor". Expert Review of Obstetrics & Gynecology. 3 (2): 163–174. doi:10.1586/17474108.3.2.163. ISSN 1747-4108.
Lamont CD, Jørgensen JS, Lamont RF (September 2016). "The safety of tocolytics used for the inhibition of preterm labour". Expert Opinion on Drug Safety. 15 (9): 1163–1173. doi:10.1080/14740338.2016.1187128. PMID 27159501. S2CID 4937942. It was for this reason and the fact that Tractocile (atosiban) only had a short duration before it was out of patent that the parent drug company decided not to pursue licensing in the USA.
Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatsonis DN (June 2014). "Oxytocin receptor antagonists for inhibiting preterm labour". The Cochrane Database of Systematic Reviews (6): CD004452. doi:10.1002/14651858.CD004452.pub3. PMC 11086629. PMID 24903678.
Saleh SS, Al-Ramahi MQ, Al Kazaleh FA (January 2013). "Atosiban and nifedipine in the suppression of pre-term labour: a comparative study". Journal of Obstetrics and Gynaecology. 33 (1): 43–45. doi:10.3109/01443615.2012.721822. PMID 23259877. S2CID 20753923.
Salim R, Garmi G, Nachum Z, Zafran N, Baram S, Shalev E (December 2012). "Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial". Obstetrics and Gynecology. 120 (6): 1323–1331. doi:10.1097/aog.0b013e3182755dff. PMID 23168756. S2CID 22487349.
de Heus R, Mulder EJ, Derks JB, Visser GH (June 2009). "The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow". The Journal of Maternal-Fetal & Neonatal Medicine. 22 (6): 485–490. doi:10.1080/14767050802702349. PMID 19479644. S2CID 35810758.
Shim JY, Park YW, Yoon BH, Cho YK, Yang JH, Lee Y, Kim A (November 2006). "Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women". BJOG. 113 (11): 1228–1234. doi:10.1111/j.1471-0528.2006.01053.x. PMID 16978233. S2CID 27031083.

drugs.com

"Atosiban International Drug Names". Drugs.com. 10 April 2020. Archived from the original on 27 December 2019. Retrieved 29 April 2020.

europa.eu

ema.europa.eu

"Tractocile EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 29 April 2020. This article incorporates text from this source, which is in the public domain.

medicines.org.uk

"Tractocile 7.5 mg/ml Solution for Injection - Summary of Product Characteristics (SmPC)". (emc). Retrieved 29 April 2020.
"Tractocile 7.5 mg/ml Concentrate for Solution for Infusion - Summary of Product Characteristics (SmPC)". (emc). 24 June 2013. Retrieved 29 April 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Akerlund M, Carlsson AM, Melin P, Trojnar J (1985). "The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin". Acta Obstetricia et Gynecologica Scandinavica. 64 (6): 499–504. doi:10.3109/00016348509156728. PMID 4061066. S2CID 25799128.
Sanu O, Lamont RF (April 2010). "Critical appraisal and clinical utility of atosiban in the management of preterm labor". Therapeutics and Clinical Risk Management. 6: 191–199. doi:10.2147/tcrm.s9378. PMC 2861440. PMID 20463780.
Chou PY, Wu MH, Pan HA, Hung KH, Chang FM (June 2011). "Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study". Taiwanese Journal of Obstetrics & Gynecology. 50 (2): 136–140. doi:10.1016/j.tjog.2011.04.003. PMID 21791296.
Lan VT, Khang VN, Nhu GH, Tuong HM (September 2012). "Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure". Reproductive Biomedicine Online. 25 (3): 254–260. doi:10.1016/j.rbmo.2012.05.014. PMID 22818095.
Wu MY, Chen SU, Yang YS (December 2011). "Using atosiban in uterine contractions of early pregnancies after assisted reproduction". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 110 (12): 800. doi:10.1016/j.jfma.2011.11.016. PMID 22248840.
Conde-Agudelo A, Romero R, Kusanovic JP (February 2011). "Nifedipine in the management of preterm labor: a systematic review and metaanalysis". American Journal of Obstetrics and Gynecology. 204 (2): 134.e1–134.20. doi:10.1016/j.ajog.2010.11.038. PMC 3437772. PMID 21284967.
Lamont CD, Jørgensen JS, Lamont RF (September 2016). "The safety of tocolytics used for the inhibition of preterm labour". Expert Opinion on Drug Safety. 15 (9): 1163–1173. doi:10.1080/14740338.2016.1187128. PMID 27159501. S2CID 4937942. It was for this reason and the fact that Tractocile (atosiban) only had a short duration before it was out of patent that the parent drug company decided not to pursue licensing in the USA.
Coomarasamy A, Knox EM, Gee H, Khan KS (November 2002). "Oxytocin antagonists for tocolysis in preterm labour -- a systematic review". Medical Science Monitor. 8 (11): RA268 – RA273. PMID 12444392.
Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatsonis DN (June 2014). "Oxytocin receptor antagonists for inhibiting preterm labour". The Cochrane Database of Systematic Reviews (6): CD004452. doi:10.1002/14651858.CD004452.pub3. PMC 11086629. PMID 24903678.
Saleh SS, Al-Ramahi MQ, Al Kazaleh FA (January 2013). "Atosiban and nifedipine in the suppression of pre-term labour: a comparative study". Journal of Obstetrics and Gynaecology. 33 (1): 43–45. doi:10.3109/01443615.2012.721822. PMID 23259877. S2CID 20753923.
Salim R, Garmi G, Nachum Z, Zafran N, Baram S, Shalev E (December 2012). "Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial". Obstetrics and Gynecology. 120 (6): 1323–1331. doi:10.1097/aog.0b013e3182755dff. PMID 23168756. S2CID 22487349.
de Heus R, Mulder EJ, Derks JB, Visser GH (June 2009). "The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow". The Journal of Maternal-Fetal & Neonatal Medicine. 22 (6): 485–490. doi:10.1080/14767050802702349. PMID 19479644. S2CID 35810758.
Shim JY, Park YW, Yoon BH, Cho YK, Yang JH, Lee Y, Kim A (November 2006). "Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women". BJOG. 113 (11): 1228–1234. doi:10.1111/j.1471-0528.2006.01053.x. PMID 16978233. S2CID 27031083.

ncbi.nlm.nih.gov

Sanu O, Lamont RF (April 2010). "Critical appraisal and clinical utility of atosiban in the management of preterm labor". Therapeutics and Clinical Risk Management. 6: 191–199. doi:10.2147/tcrm.s9378. PMC 2861440. PMID 20463780.
Conde-Agudelo A, Romero R, Kusanovic JP (February 2011). "Nifedipine in the management of preterm labor: a systematic review and metaanalysis". American Journal of Obstetrics and Gynecology. 204 (2): 134.e1–134.20. doi:10.1016/j.ajog.2010.11.038. PMC 3437772. PMID 21284967.
Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatsonis DN (June 2014). "Oxytocin receptor antagonists for inhibiting preterm labour". The Cochrane Database of Systematic Reviews (6): CD004452. doi:10.1002/14651858.CD004452.pub3. PMC 11086629. PMID 24903678.

semanticscholar.org

api.semanticscholar.org

Akerlund M, Carlsson AM, Melin P, Trojnar J (1985). "The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin". Acta Obstetricia et Gynecologica Scandinavica. 64 (6): 499–504. doi:10.3109/00016348509156728. PMID 4061066. S2CID 25799128.
Lamont CD, Jørgensen JS, Lamont RF (September 2016). "The safety of tocolytics used for the inhibition of preterm labour". Expert Opinion on Drug Safety. 15 (9): 1163–1173. doi:10.1080/14740338.2016.1187128. PMID 27159501. S2CID 4937942. It was for this reason and the fact that Tractocile (atosiban) only had a short duration before it was out of patent that the parent drug company decided not to pursue licensing in the USA.
Saleh SS, Al-Ramahi MQ, Al Kazaleh FA (January 2013). "Atosiban and nifedipine in the suppression of pre-term labour: a comparative study". Journal of Obstetrics and Gynaecology. 33 (1): 43–45. doi:10.3109/01443615.2012.721822. PMID 23259877. S2CID 20753923.
Salim R, Garmi G, Nachum Z, Zafran N, Baram S, Shalev E (December 2012). "Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial". Obstetrics and Gynecology. 120 (6): 1323–1331. doi:10.1097/aog.0b013e3182755dff. PMID 23168756. S2CID 22487349.
de Heus R, Mulder EJ, Derks JB, Visser GH (June 2009). "The effects of the tocolytics atosiban and nifedipine on fetal movements, heart rate and blood flow". The Journal of Maternal-Fetal & Neonatal Medicine. 22 (6): 485–490. doi:10.1080/14767050802702349. PMID 19479644. S2CID 35810758.
Shim JY, Park YW, Yoon BH, Cho YK, Yang JH, Lee Y, Kim A (November 2006). "Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women". BJOG. 113 (11): 1228–1234. doi:10.1111/j.1471-0528.2006.01053.x. PMID 16978233. S2CID 27031083.

web.archive.org

"Atosiban International Drug Names". Drugs.com. 10 April 2020. Archived from the original on 27 December 2019. Retrieved 29 April 2020.

worldcat.org

search.worldcat.org

Lamont RF, Kam KY (March 2008). "Atosiban as a tocolytic for the treatment of spontaneous preterm labor". Expert Review of Obstetrics & Gynecology. 3 (2): 163–174. doi:10.1586/17474108.3.2.163. ISSN 1747-4108.